SUSAN DAVIN: Open Payments
NPI 1871598623 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,528 in 67 payments from 11 companies in 2025. Trend: 2023 $616 · 2024 $1,165 · 2025 $1,528
Food & beverage: $1,528
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $529 |
| E.R. Squibb & Sons, L.L.C. | 11 | $444 |
| Otsuka America Pharmaceutical, Inc. | 13 | $144 |
| Vanda Pharmaceuticals Inc. | 7 | $140 |
| Axsome Therapeutics, Inc. | 5 | $116 |
| Lundbeck LLC | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Alkermes, Inc. | 2 | $30 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $21 |
Products named: CAPLYTA, COBENFY, REXULTI, FANAPT, Auvelity, Qelbree, Jornay PM, Quviviq.
Industry payments across CA — which companies pay providers there.
